NAtalizumab for Prevention of Post-partum Relapses in patients with Multiple Sclerosis 09May2016
Primary Objective
To assess the efficacy of IV administered natalizumab, monthly for 1 year, in preventing relapses during the postpartum period.
This Study is
No Longer Enrolling
Details
Age
Adult
Type of Study
Treatment
Locations
University of Colorado Hospital
Study ID
Protocol Number: 16-0156
Categories
Not finding the right Study for you? Join ResearchMatch, a nation-wide registry connecting volunteers and researchers